Catalyst Brief

← Calendar

Readoutin 14d

Sound Pharmaceuticals, Incorporated — Ebselen

Phase 3 primary completion: SPI-1005 for the Treatment of Meniere's Disease (Open Label).

Date
Dec 2026
Type
Readout
Indication
Meniere's Disease

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.